tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Medexus Pharmaceuticals Announces First Fiscal Quarter 2026 Conference Call
PremiumCompany AnnouncementsMedexus Pharmaceuticals Announces First Fiscal Quarter 2026 Conference Call
2M ago
Medexus Pharmaceuticals’ GRAFAPEX™ Receives NTAP Approval for 2026
Premium
Company Announcements
Medexus Pharmaceuticals’ GRAFAPEX™ Receives NTAP Approval for 2026
2M ago
Positive Outlook for Medexus Pharmaceuticals: Buy Rating Affirmed by Analyst
Premium
Ratings
Positive Outlook for Medexus Pharmaceuticals: Buy Rating Affirmed by Analyst
3M ago
Medexus Secures Public Reimbursement for Trecondyv® in Quebec
PremiumCompany AnnouncementsMedexus Secures Public Reimbursement for Trecondyv® in Quebec
5M ago
Medexus Reports Strong Initial Uptake of GRAFAPEX™ in U.S. Market
Premium
Company Announcements
Medexus Reports Strong Initial Uptake of GRAFAPEX™ in U.S. Market
6M ago
Medexus Returns Gleolan U.S. Rights to NX Development Corp.
Premium
Company Announcements
Medexus Returns Gleolan U.S. Rights to NX Development Corp.
7M ago
Medexus Pharmaceuticals Reports Strong Q3 2025 Results Amidst Strategic Growth
PremiumCompany AnnouncementsMedexus Pharmaceuticals Reports Strong Q3 2025 Results Amidst Strategic Growth
8M ago
Medexus Secures Ontario Public Reimbursement for Trecondyv
Premium
Company Announcements
Medexus Secures Ontario Public Reimbursement for Trecondyv
8M ago
MDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100